group IVF sPLA₂ Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of group IVF sPLA₂ monoclonal antibodies for advanced research in lipid metabolism and inflammation. Group IVF sPLA₂ monoclonal antibodies demonstrate high effectiveness across multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Group IVF sPLA₂ (secreted phospholipase A2) catalyzes the hydrolysis of phospholipids, releasing fatty acids and lysolipids that act as key mediators in inflammatory responses. Group IVF sPLA₂ influences numerous physiological processes, including cell signaling, membrane remodeling, and immune response modulation. Research into group IVF sPLA₂ continues to reveal its significance in pathophysiological conditions, such as cardiovascular diseases and neuroinflammation. Investigating group IVF sPLA₂ function provides valuable insights into cellular mechanisms and potential therapeutic targets. Understanding group IVF sPLA₂ activity helps researchers develop new strategies for treating inflammatory disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic approaches for various diseases.